Certain Cancer Therapies May Rarely Lead to Hypoparathyroidism, Case Study Reports
Immune checkpoint inhibitors (ICIs), a type of immune therapy used to treat some cancers, may lead to the development of immune-related hypoparathyroidism, according to a case report. Although rare, this case adds to three other similar cases and to an increasing number of reports describing immune-related hormone diseases…